1-(2-bromophenoxy)-3-pyrrolidin-1-ylpropan-2-ol, 95.0%, 1g

4-Methoxy-2-nitrobenzoic Acid>98.0%(GC)(T)5g

(Chloromethoxy)cyclohexane, 98%, 1g

Ethylene glycol-O,O'-bis(2-aminoethyl)-N,N,N',N'-tetraacetic acid, 97.0%, 1g

2,4-Diisopropylpyridin-3-amine, 95%, 100mg

6-Bromo-1H-pyrrolo[3,2-c]pyridine, 95.0%, 25g

Methyl 2-(2-bromothiazol-4-yl)acetate, 97%, 100mg

(4R,E)-4-((1R,3aS,7aR,E)-4-((E)-2-((3S,5R)-3,5-bis((tert-butyldimethylsilyl)oxy)-2-methylenecyclohexylidene)ethylidene)-7a-methyloctahydro-1H-inden-1-yl)-1-cyclopropylpent-2-en-1-ol, 98%, 5g

N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-L-proline>98.0%(HPLC)(T)25g

2,5-Dichloropyridine-3,4-diamine, 95.0%, 1g

1-Benzylpiperidin-3-one; hydrochloride, 97.0%, 100g

(E)-1-((3,7-DIMETHYLOCTA-2,6-DIEN-1-YL)SULFONYL)-4-METHYLBENZENE, 95.0%, 100mg

5-Norbornen-2-yl Acetate (endo- and exo- mixture)>96.0%(GC)100g